BCL2 and glioma: In glioma cells, GLIPR1 overexpression reduced c-Jun N-terminal kinase (JNK) phosphorylation and induced Bcl-2 expression, thus increasing cell survival and glioma cells’ protective effect against apoptotic stimuli such as Fas ligation, chemotherapy, and radiation treatment[132].